logo

News

Newspapers stacked
DNA underlay

News

Nasdaq compliance

Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements

July 7th, 2025

Read More

adnas logo

Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx

June 30th, 2025

Read More

Dr. James Hayward

Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward

June 17th, 2025

Read More

adnas logo

Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3’25 Financial Results Report in Mid-August 

June 16th, 2025

Read More

adnas logo

Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17

May 29th, 2025

Read More

adnas logo

Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025

May 29th, 2025

Read More

adnas logo

Applied DNA Reports Second Quarter Fiscal 2025 Financial Results

May 15th, 2025

Read More

apdn circle logo

Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3

May 14th, 2025

Read More

synthetic dna

Applied DNA’s LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA

April 21st, 2025

Read More